Lenskart Solutions Ltd.
LENSKART · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹169.42.
Piotroski F-score 3/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%6.7%
- ✓Low debt (D/E < 0.5)0.35x
- ✕Positive free cash flow
- ✓Revenue growth > 10%46%
- ✕Earnings growing-11%
- ✕Net margin ≥ 10%5.6%
- ✓Current ratio > 1.52.26
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- –Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 10.2
- ✕Piotroski ≥ 73/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 10.2.
Weaknesses
- •Low return on equity (6.7%).
- •Weak Piotroski score (3/9).
Opportunities
- •Revenue growing (46% YoY).
Threats
- •Earnings contracting year on year.
- •Rich valuation versus sector peers.
- •Trades ~58% above our estimated fair value.
About Lenskart Solutions Ltd.
Lenskart Solutions Limited, a technology-driven eyewear company, engages in designing, manufacturing, branding, and retailing of eyewear products in India, Japan, Southeast Asia, and the Middle East. The company's products include prescription eyeglasses, sunglasses, goggles, screen glasses, and other products, such as contact lenses and eyewear accessories, including frames for men, women, and kids. It engages in lens manufacturing, lens edging, lens design, frame design, fr
More in Consumer Services
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.